Neurogene Inc. — Director's Dealing 2015

Nov 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AQUINOX PHARMACEUTICALS, INC (AQXP)
CIK: 0001404644
Period of Report: 2015-10-31

Reporting Person: Bridger Gary (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-31	Common Stock	J	1543989	$0.00	Disposed	0	Indirect

Footnotes

F1: Dr. Bridger is a managing director of Five Corners Capital Inc., which was the general partner of Ventures West 8 Limited Partnership. Effective October 31, 2015, Five Corners Capital Inc. ceased to be the general partner of Ventures West 8 Limited Partnership. Therefore, Dr. Bridger no longer holds any voting or investment power with respect to shares held by Ventures West 8 Limited Partnership.